Cargando…

Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19

INTRODUCTION: The ongoing COVID-19 pandemic is placing an extraordinary burden on our health care system with its limited resources. Accurate triage of patients is necessary to ensure medical care for those most severely affected. In this regard, biomarkers could contribute to risk evaluation. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogel, Manuel J., Leininger, Simon B., Staudner, Stephan T., Hubauer, Ute, Wallner, Stefan, Mustroph, Julian, Hanses, Frank, Zimmermann, Markus, Lehn, Petra, Burkhardt, Ralph, Maier, Lars S., Hupf, Julian, Jungbauer, Carsten G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308530/ https://www.ncbi.nlm.nih.gov/pubmed/37364545 http://dx.doi.org/10.1159/000529690

Ejemplares similares

Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19
por: Vogel, Manuel J., et al.
Publicado: (2021)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
por: Reynen, Stefanie, et al.
Publicado: (2021)

Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
por: Mustroph, Julian, et al.
Publicado: (2020)

RNA-expression of adrenomedullin is increased in patients with severe COVID-19
por: Hupf, Julian, et al.
Publicado: (2020)

Niedrige Inzidenz von SARS-CoV‑2-Infektionen bei Krankenhausmitarbeitern eines Maximalversorgers: Ergebnisse einer prospektiven serologischen Kohortenstudie der ersten und zweiten COVID‑19-Welle
por: Hupf, Julian, et al.
Publicado: (2022)

Cardiac iron overload promotes cardiac injury in patients with severe COVID-19
por: Baier, Maria J., et al.
Publicado: (2021)

Two patients with out‐of‐hospital cardiac arrest
por: Hupf, Julian, et al.
Publicado: (2021)

Cardiac Fibrosis Is a Risk Factor for Severe COVID-19
por: Mustroph, Julian, et al.
Publicado: (2021)

The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
por: Roth, Nastasia, et al.
Publicado: (2022)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
por: Hauck, Christian, et al.
Publicado: (2021)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
por: Hauck, Christian, et al.
Publicado: (2022)

Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients
por: Koch, Alexander, et al.
Publicado: (2011)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure
por: Grois, Laura, et al.
Publicado: (2017)

Serum and Urinary N-Terminal Pro-brain Natriuretic Peptides as Biomarkers for Bronchopulmonary Dysplasia of Preterm Neonates
por: Iliodromiti, Zoi, et al.
Publicado: (2020)

N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population
por: Lee, Kyung-Hoon, et al.
Publicado: (2010)

Prognostic value of amino terminal pro-b-type natriuretic peptide in septic patients
por: Maroto, Fernando, et al.
Publicado: (2008)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

CaMKII regulation of cardiac K channels
por: Mustroph, Julian, et al.
Publicado: (2014)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Predictive value of N-terminal pro-brain natriuretic peptide among critically ill patients
por: Cubrilo-Turek, M, et al.
Publicado: (2012)

Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome
por: Bao, Yuanyuan, et al.
Publicado: (2011)

Comparison of N-Terminal Pro B-Natriuretic Peptide and Echocardiographic Indices in Patients with Mitral Regurgitation
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2010)

Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
por: Liu, Hua, et al.
Publicado: (2013)

Plasma N-Terminal Pro B-Type Natriuretic Peptide Concentrations in Dogs with Pulmonic Stenosis
por: KOBAYASHI, Keiya, et al.
Publicado: (2014)

N-terminal pro-B-type natriuretic peptide in patients after cervical spine surgery
por: Spatenkova, V, et al.
Publicado: (2006)

Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease
por: Dallmeier, Dhayana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nnvjlromg74vpfs76pogkup1cc